[
    [
        {
            "time": "2021-05-11",
            "original_text": "复星医药(600196)重大事项点评：与BIONTECH成立JV 打造全球领先的mRNA技术平台",
            "features": {
                "keywords": [
                    "复星医药",
                    "BIONTECH",
                    "JV",
                    "mRNA技术平台"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(600196)重大事项点评：与BIONTECH成立JV 打造全球领先的mRNA技术平台",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "复星医药(600196.SH)：复宏汉霖就BRAFV600E抑制剂与润新生物签订许可协议",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "BRAFV600E抑制剂",
                    "润新生物",
                    "许可协议"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：复宏汉霖就BRAFV600E抑制剂与润新生物签订许可协议",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "【权益变动】复星医药(02196.HK)获摩根大通增持677.1531万股",
            "features": {
                "keywords": [
                    "复星医药",
                    "摩根大通",
                    "增持"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【权益变动】复星医药(02196.HK)获摩根大通增持677.1531万股",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "北向资金今日净流出47.81亿元 五粮液获净买入6.44亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流出",
                    "五粮液",
                    "净买入"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金今日净流出47.81亿元 五粮液获净买入6.44亿元",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "策略日报：指数震荡分化 资源类板块领涨",
            "features": {
                "keywords": [
                    "指数",
                    "震荡分化",
                    "资源类板块",
                    "领涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "资源类"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "策略日报：指数震荡分化 资源类板块领涨",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "东吴证券维持复星医药买入评级：拟与BioNTech投资设立合资公司 长期看好mRNA新冠疫苗市场前景",
            "features": {
                "keywords": [
                    "东吴证券",
                    "复星医药",
                    "BioNTech",
                    "合资公司",
                    "mRNA新冠疫苗",
                    "市场前景"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "东吴证券维持复星医药买入评级：拟与BioNTech投资设立合资公司 长期看好mRNA新冠疫苗市场前景",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "瑞信指复星医药(02196-HK)与BioNTech设合营为利好 升目标价至60港元",
            "features": {
                "keywords": [
                    "瑞信",
                    "复星医药",
                    "BioNTech",
                    "合营",
                    "目标价"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "瑞信指复星医药(02196-HK)与BioNTech设合营为利好 升目标价至60港元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "快速扩产！BioNTech在新加坡设立区域总部和mRNA疫苗工厂",
            "features": {
                "keywords": [
                    "BioNTech",
                    "新加坡",
                    "区域总部",
                    "mRNA疫苗工厂"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "快速扩产！BioNTech在新加坡设立区域总部和mRNA疫苗工厂",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-11",
            "original_text": "一天飙涨25% 游资、机构齐聚复星医药龙虎榜 私募人士提醒",
            "features": {
                "keywords": [
                    "飙涨",
                    "游资",
                    "机构",
                    "龙虎榜",
                    "复星医药",
                    "私募人士提醒"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一天飙涨25% 游资、机构齐聚复星医药龙虎榜 私募人士提醒",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]